Structure of the human TWIK-2 potassium channel and its inhibition by pimozide
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2425709122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Nandish K Khanra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Structural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065. Hauptthemen laut MEDLINE: Pimozide, Potassium Channels, Tandem Pore Domain, Potassium Channel Blockers. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, HHS | NIH | National Institute of General Medical Sciences (NIGMS), Simons Foundation (SF).
Abstract (Originalsprache)
The potassium channel TWIK-2 is crucial for ATP-induced activation of the NLRP3 inflammasome in macrophages. The channel is a member of the two-pore domain potassium (K2P) channel superfamily and an emerging therapeutic target to mitigate severe inflammatory injury involving NLRP3 activation. We report the cryo-EM structure of human TWIK-2. In comparison to other K2P channels, the structure reveals an unusual “up” conformation of Tyr111 in the selectivity filter and a resulting SF1-P1 pocket behind the filter. Density for acyl chains is present in fenestrations within the transmembrane region that connects the central cavity of the pore to the lipid membrane. Despite its importance as a drug target, limited pharmacological tools are available for TWIK-2. A previous study suggested that the FDA-approved small molecule pimozide might inhibit TWIK-2. Using a reconstituted system, we show that pimozide directly inhibits the channel and we determine a cryo-EM structure of a complex with the drug. Pimozide displaces the acyl chains within the fenestrations and binds below the selectivity filter where it would impede ion permeation. The drug may access its binding site by lateral diffusion in the membrane, suggesting that other hydrophobic small molecules could have utility for inhibiting TWIK-2. The work defines the structure of TWIK-2 and provides a structural foundation for development of more specific inhibitors with potential utility as anti-inflammatory drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Structural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
- Graduate Program in Biochemistry and Structural Biology, Cell and Developmental Biology, and Molecular Biology, Weill Cornell Medicine Graduate School of Medical Sciences, New York, NY 10065.
ORCID-Profile: Nandish K Khanra, Bryce D Delgado, Stephen B Long
Förderung
- NIGMS NIH HHS
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- Simons Foundation (SF)
- HHS | NIH | NCI | Center for Cancer Research (CCR)
- NCI NIH HHS
Zitieren
APA
Khanra, N. K., Wang, C., Delgado, B. D., & Long, S. B. (2025). Structure of the human TWIK-2 potassium channel and its inhibition by pimozide. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2425709122
Vancouver
Khanra NK, Wang C, Delgado BD, Long SB. Structure of the human TWIK-2 potassium channel and its inhibition by pimozide. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2425709122
BibTeX
@article{Khanra2025,
author = {Khanra, Nandish K and Wang, Chongyuan and Delgado, Bryce D and Long, Stephen B},
title = {Structure of the human TWIK-2 potassium channel and its inhibition by pimozide},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2425709122}
}
EUVIMED